Sempra Q3 Adjusted EPS Rises to $1.40; Oncor Capital Plan Up 20%
Image
SAN DIEGO – November 05, 2026 -- Sempra (NYSE: SRE) reported third-quarter 2026 adjusted earnings of $917 million, or $1.40 per diluted share, up from $728 million, or $1.11 per share, a year earlier, and said its Oncor unit expects to raise its base capital plan by roughly 20%.
GAAP earnings reached $877 million, or $1.34 per diluted share, against $77 million, or $0.12 per share, in the third quarter of 2025. For the first nine months, GAAP earnings were $2.710 billion ($4.13 per share), compared with $1.444 billion ($2.21 per share) a year earlier. Nine-month adjusted earnings were $2.670 billion ($4.07 per share), up from $2.253 billion ($3.45 per share).